Open Access Pub · Peer-reviewed · Open access
Journal of Advanced Pharmaceutical Science and Technology
JAPST ISSN 2328-0182 Crossref DOI prefix 10.14302 CC BY 4.0
JAPST publishes research on medicines: their discovery, properties, biological effects, formulation, manufacture, quality, safety and use in practice.
Research and reviews are published open access under a Creative Commons Attribution 4.0 license, authors retain copyright, and registered articles are deposited with Crossref under the journal's own DOI prefix. Submissions are accepted throughout the year.
- Published record 36 articles3 volumes · 9 issues
- Publication history 2013–2024Latest issue: Volume 3, Issue 1
- Editorial board 77 members24 countries · 39 with a registered ORCID iD
- Article processing charge USD 2,100USD 720 student rate · charged after acceptance
What the journal publishes
A submission should make a clear contribution to pharmaceutical knowledge, technology, medicine safety or pharmacy practice. A new formulation or manufacturing process is not required for every study.
Article formats: Original research articles; Review articles; Case reports; Short communications and technical notes; Methods and protocols; Perspectives, commentaries and policy analyses.
Drug discovery and pharmaceutical chemistry
Medicinal chemistry, drug and prodrug design, lead identification and optimization, structure–activity relationships, target validation and computational drug discovery. Chemical and molecular studies should establish their relevance to a drug, therapeutic target or pharmaceutical problem.
Pharmacology, pharmacokinetics and toxicology
Drug mechanisms, pharmacodynamics, dose–response relationships, pharmacokinetics, absorption, distribution, metabolism and excretion, drug interactions, safety pharmacology and toxicology. Studies may address experimental systems or clinical drug response without requiring formulation innovation.
Pharmacognosy and natural products
Phytochemistry, medicinal natural products, bioactive constituents, herbal medicines and ethnopharmacology with a defined pharmaceutical question. Work may examine identity, composition, biological activity, safety, standardization or quality, using authenticated materials and methods appropriate to the claims.
Pharmaceutics, drug delivery and biopharmaceutics
Preformulation, physical pharmacy, excipients, dosage forms, controlled and targeted delivery, nanomedicines and pharmaceutical biomaterials. Biopharmaceutics includes dissolution, permeability, bioavailability, bioequivalence and relationships between drug properties, dosage forms and biological performance.
Pharmaceutical analysis and bioanalysis
Analytical method development and validation, drug and metabolite measurement, impurity and adulterant detection, stability-indicating assays, spectroscopy, chromatography, dissolution testing and process analytical technology. Methods should be evaluated for their intended pharmaceutical or bioanalytical use.
Pharmaceutical technology, manufacturing and quality
Process development, pharmaceutical engineering, scale-up, continuous manufacturing, stability, packaging, quality control and assurance, quality by design, validation and technology transfer. Regulatory science includes evidence and methods supporting pharmaceutical quality, safety, efficacy and regulatory evaluation.
Pharmaceutical biotechnology
Therapeutic proteins, peptides, antibodies, vaccines and nucleic-acid therapeutics; their discovery, biological evaluation, characterization, formulation, delivery or production. Biotechnology and bioinformatics fit when the pharmaceutical application is part of the research question.
Clinical, translational and pharmacy-practice research
JAPST also welcomes clinical pharmacology, pharmacotherapy, therapeutic drug monitoring, pharmacogenetics and pharmacogenomics, pharmacovigilance, pharmacoepidemiology and pharmacoeconomics. Clinical, hospital, community, social and public-health pharmacy studies may address prescribing, drug utilization, adherence, interactions, access to medicines, medication safety or pharmaceutical-care services. Their contribution can concern the use and effects of existing medicines; a new product or formulation is not a condition of scope.
Research from adjacent disciplines fits when its objectives, methods and interpretation address a substantive pharmaceutical question. Merely mentioning a medicine does not establish scope fit.
Full aims and scope Instructions for authors Call for papers
From the published record
Selected articles from the publication record, most recent first. Every record below carries a registered Crossref DOI that resolves to the version of record.
A Review on Drug Design by the Application of Computer
Nikita S. Patil, Harsha S. Suryawanshi, Azam Z. Shaikh, S. P. Pawar
Evaluation of Acacia- Guar Gum Combination as Delayed Release Coating Former on Solid Placebo Tablets
Suad Y. Alkarib, Deina E. MohamedElhassan
Review article on Analytical Techniques of Lamivudine Determination in Different Matrices
Roshdy E. Saraya, Magda Elhenawee, Hanaa Saleh, Mahmoud M. Sebaiy
Identification and Quantification of an Adulterant in a Dietary Supplement Marketed for Sexual Enhancement
Flavia Redko, Sabrina Flor, Silvia Lucangioli, Jerónimo Ulloa, Rafael Ricco, Claudio Fernández, Luis Sambrotta, Liliana Muschietti
Evaluating the Efficacy of Gene Silencing in Dopaminergic Neuronal Cells In-Vitro using Gold Nanorods (GNR) with Different Surface Properties Complexed to DARPP-32 siRNA.
Atcha Kopwitthaya, Wing Cheung Law, Lisa A Vathy, Ravikumar Aalinkeel, Jessica L. Reynolds, Bindukumar Nair, Supriya D. Mahajan
Who handles the manuscripts
Manuscripts are handled by an editorial board of 77 members working in 24 countries, 39 of whom publish an ORCID iD. Editors listed below work in pharmaceutics, drug delivery, pharmaceutical analysis and pharmacology; each iD opens the editor's own registry record.
Tao Pang Ph.D.
Professor, China Pharmaceutical University, Nanjing, Jiangsu · China
Vikas Anand Saharan
Associate Professor, National Institute of Pharmaceutical Education and Research, Guwahati, Assam · India
Paolo Blasi
Associate Professor, Alma Mater Studiorum - Università di Bologna, Bologna · Italy
Malay K Das
Dibrugarh University Department of Pharmaceutical Sciences, Dibrugarh · India
Lucia Martin-Banderas
University of Seville, Spain · Spain
View the full editorial board Editorial policies For editors For reviewers
How the journal works
All submissions undergo initial editorial screening. Manuscripts that meet the journal's scope and minimum requirements proceed to independent peer review. Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts.
Editorial decisions are based on scope, scientific quality, methodological rigor, ethical compliance, reporting quality, and relevance to the journal. Decisions rest with the handling editor and are independent of fees, services or any role an author holds with the journal. The article processing charge is raised only after a manuscript has been accepted.
Articles are published open access under CC BY 4.0. Authors retain copyright and readers may reuse the work with attribution. Registered articles are deposited with Crossref under the prefix 10.14302, so the version of record can be cited and resolved permanently.
What submitted work must carry
- Human studies require appropriate ethics approval and informed consent; animal studies require appropriate ethics and welfare approval.
- Interventional clinical trials must be registered in an accepted public trial registry at or before the first participant provides consent for enrollment. The registry name, registration number, and registration date must be reported in the manuscript.
- Every empirical research manuscript must include a data-availability statement.
- Competing interests and funding sources must be disclosed.
- Authorship must reflect substantial contribution to the work.
- Errors identified after publication are addressed through published corrections or retractions.
- Peer review
- Single-blind by default; double-blind review is available on request.
- License
- Creative Commons Attribution 4.0. Authors retain copyright.
- DOI registration
- Crossref, prefix 10.14302.
- Article processing charge
- USD 2,100 standard, USD 720 student rate. Charged after acceptance only — see the article processing charges page.
- Research integrity
- Ethics, competing-interest, authorship, data-availability and correction requirements are set out in the editorial policies.
- Copyright and reuse
- Terms are stated on the copyright and license page.
Identifiers and discovery
Registration, identifiers and discovery services are separate things, and each row below links to a record a reader can open. The journal's full statement on discovery is on the indexing page.
- Journal identifier
- ISSN 2328-0182 — the journal's registered international serial identifier. ISSN Portal record
- DOI registration
- Registered articles carry a Crossref DOI under the prefix 10.14302, so the version of record can be cited and resolved permanently. Crossref record
- Scholarly discovery
- The journal and its articles are represented in the OpenAlex open catalog of scholarly works. OpenAlex source record (API)
- Author identifiers
- Editors and authors are displayed with their ORCID iD where one has been supplied.
How to submit
ManuscriptZone
The journal's submission system. Create a submission and track it from lodgement to decision.
Authors who would rather not open a portal account can use the manuscript submission form, or send the manuscript to the editorial office at [email protected] and the team will lodge it. Authors must use only one submission route for the same manuscript.
Preparation requirements Article processing charges Submission routes in full
Everything else
Submit your research to JAPST
The Journal of Advanced Pharmaceutical Science and Technology welcomes submissions throughout the year across pharmaceutical science, technology and practice. Read the Aims and Scope to assess the contribution and the author instructions to choose the appropriate format.
Journal of Advanced Pharmaceutical Science and Technology (JAPST)
ISSN 2328-0182 · Crossref DOI prefix 10.14302 · Published by Open Access Pub ·
Content licensed CC BY 4.0, authors retain copyright